Associations of urological malignancies with renal progression and mortality in advanced chronic kidney disease: a propensity-matched cohort study
AffiliationDepartment of Renal Medicine, Salford Royal NHS Foundation Trust, Salford, M6 8HD
MetadataShow full item record
AbstractBackground: Urological malignancy (UM) in patients with chronic kidney disease (CKD) is an added burden to their overall morbidity and mortality. UM is itself a common cause of CKD. Understanding the associations of UM with outcomes in advanced CKD can help in optimisation of the management of these patients. This study investigates the distribution and association of urological malignancy with outcomes (renal progression and mortality) in patients with advanced non-dialysis dependent CKD. Methods: The study was conducted in 2637 of 3115 patients recruited in the Salford Kidney Study between the years 2002 and 2016. A comparative analysis was performed between 160 patients with UM (at baseline and incident) and 2477 patients with no malignancy. Cox-regression models and Kaplan-Meir estimates were used to explore the association between the presence of UM with mortality and renal outcome. Linear regression analysis was used to calculate the rate of progression of CKD in the groups. A 1:3 propensity score matched cohort of 640 patients was generated and utilised in the above analyses. Results: 4.4% had a history of UM at baseline with the annual incident rate being 0.37%. The site of malignancy was the kidney in 40% with comparable numbers for prostatic malignancy (39%). 70% (111/160) of UM patients had a medical cause as their primary diagnosis for CKD. Over a median follow up of 4 years, 34% (905) patients died. In the matched sample, the proportion of deaths was similar between the groups (UM 44% versus no malignancy 48%, p = 0.36). 30% reached end-stage renal disease (ESRD) with no difference between the groups. In the Cox-regression model, UM did not prove to be a risk factor associated with either all-cause mortality (HR:1.03; CI: 0.79-1.35; p = 0.81) or reaching ESRD (HR:1.12; CI: 0.80-1.58; p = 0.49). The rate of decline in estimated glomerular filtration rate (eGFR) was similar between the groups (- 1.05 vs - 1.25 mL/min/1.73m2/year, p = 0.31). Conclusions: There was no correlation observed between UM and all-cause mortality or ESRD. Medical causes of CKD have a significant influence on the outcomes in patients with UM, whereas the UM did not. Hence, a coordinated approach with early liaison between the urology and nephrology teams is needed in the management of UM patients with CKD.
CitationChinnadurai R, Clarke NW, Kalra PA. Associations of urological malignancies with renal progression and mortality in advanced chronic kidney disease: a propensity-matched cohort study. BMC Nephrol. 2020;21(1):202.
- Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort study.
- Authors: Chinnadurai R, Flanagan E, Jayson GC, Kalra PA
- Issue date: 2019 Oct 22
- Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
- Authors: Yang W, Xie D, Anderson AH, Joffe MM, Greene T, Teal V, Hsu CY, Fink JC, He J, Lash JP, Ojo A, Rahman M, Nessel L, Kusek JW, Feldman HI, CRIC Study Investigators.
- Issue date: 2014 Feb
- Distribution and association of cancer with mortality in end-stage renal disease patients receiving dialysis.
- Authors: Chinnadurai R, Flanagan E, Kalra PA
- Issue date: 2019 Dec
- Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD.
- Authors: Bowe B, Xie Y, Xian H, Li T, Al-Aly Z
- Issue date: 2017 Apr 3
- Lung Function and Incident Kidney Disease: The Atherosclerosis Risk in Communities (ARIC) Study.
- Authors: Sumida K, Kwak L, Grams ME, Yamagata K, Punjabi NM, Kovesdy CP, Coresh J, Matsushita K
- Issue date: 2017 Nov